Results 1 to 10 of about 20,467 (239)

Image-processing pipeline for diagnosing diabetic macular ischaemia in diabetic macular oedema [PDF]

Scientific Reports
Diabetic Macular Ischaemia (DMI) is a critical cause of vision loss, frequently occurring alongside Diabetic Macular Oedema (DMO) in patients with severe diabetic retinopathy.
Xiaofan Xiong, Maged Habib, David H. Steel, Chingning Taffeta Yamaguchi, Tunde Peto, Boguslaw Obara   +5 more
doaj   +5 more sources

Diabetic Macular Oedema Guidelines: An Australian Perspective [PDF]

Journal of Ophthalmology, 2023
The number of people living with diabetes is expected to rise to 578 million by 2030 and to 700 million by 2045, exacting a severe socioeconomic burden on healthcare systems around the globe.
Yew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, Jaskirat S. Aujla, Hemal Mehta, Sanj Wickremasinghe, Gurmit Uppal, Jennifer Arnold, Fred Chen, Andrew Chang, Samantha Fraser-Bell, Lyndell Lim, Janika Shah, Ellie Bowditch, Geoffrey K. Broadhead   +14 more
doaj   +4 more sources

Macular Thickness- An Early Predictor of Diabetic Macular Oedema [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Diabetic Macular Oedema (DME) accounts for visual morbidity in about three-fourth of Diabetic Retinopathy (DR) patients. Traditional examination on 90D slit lamp or stereoscopic fundus photograph may not be able to identify early ...
Chandrika Sareddy, Shubha Nagpal, Deepa Muzumdar   +2 more
doaj   +2 more sources

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Cells, 2021
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular ...
Milagros Mateos-Olivares, Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rogelio González-Sarmiento, Maribel Lopez-Galvez, J. Carlos Pastor, Ricardo Usategui-Martín, Salvador Pastor-Idoate   +7 more
doaj   +3 more sources

The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract [PDF]

BMC Ophthalmology, 2005
Background The management of diabetic patients with refractory macular oedema or patients with no adequate pre-operative view to administer laser treatment provide a challenge to the ophthalmologist.
Cannon Paul S, Habib Maged S, Steel David HW   +2 more
doaj   +3 more sources

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial [PDF]

Trials, 2019
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Noemi Lois, Evie Gardner, Norman Waugh, Augusto Azuara-Blanco, Hema Mistry, Danny McAuley, Nachiketa Acharya, Tariq M. Aslam, Clare Bailey, Victor Chong, Louise Downey, Haralabos Eleftheriadis, Samia Fatum, Sheena George, Faruque Ghanchi, Markus Groppe, Robin Hamilton, Geeta Menon, Ahmed Saad, Sobha Sivaprasad, Marianne Shiew, David H. Steel, James Stephen Talks, Catherine Adams, Christina Campbell, Matthew Mills, Mike Clarke, On behalf of the DIAMONDS Study Group   +27 more
doaj   +3 more sources

Burden of diabetic macular oedema and its associated factors among adult patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia, 2023: a multicentre cross-sectional study [PDF]

BMJ Open
Objective This study aimed to assess the prevalence of diabetic macular oedema and its associated factors among adult patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia in 2023.Design An institution-based, cross ...
Biruk Lelisa Eticha, Matiyas Mamo Bekele, Abebech Fikade Shumye, Mebratu Mulusew Tegegne, Asamere Tsegaw Woredekal   +4 more
doaj   +2 more sources

Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review

Journal of International Medical Research, 2019
Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti ...
Horace Massa, Anindyt M. Nagar, Athanasios Vergados, Panagiotis Dadoukis, Sudeshna Patra, Georgios D. Panos   +5 more
doaj   +2 more sources

Concentrated triamcinolone acetonide suprachoroidally administered for the treatment of diabetic macular oedema [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2023
Introduction/Objective. Diabetic macular oedema is the accumulation of fluid in the macular tissue leading to its thickening. The aim of the study was to evaluate the efficacy of concentrated triamcinolone acetonide 10 mg / 0.1 ml injection into the ...
Petrović Nenad, Todorović Dušan, Srećković Sunčica, Jovanović Mihailo, Šarenac-Vulović Tatjana   +4 more
doaj   +1 more source

EVALUATION OF DIABETIC AND NON-DIABETIC PATIENTS' MACULAR THICKNESS FOLLOWING CATARACT SURGERY. A PROSPECTIVE CASE-CONTROL STUDY.

Student's Journal of Health Research Africa, 2023
Background:  Diabetes accelerates cataract development. After cataract surgery, optical tissue damage causes problems. Cystoid development causes macular oedema. Edoema thickens the macula and impairs the retinal blood barrier.
Sarika Ratha, Lalita C.S, Shovna Dash, Soumya Kanta Mohanty   +3 more
doaj   +1 more source